The seven-year MS-STAT study, which involved almost 1,000 patients over 31 sites across the UK, concluded that simvastatin is ...

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

Tolebrutinib delayed the onset of disability progression by 31% for patients with a type of the disease called non-relapsing ...

Pathways to Cures Roadmap was created by a number of MS representatives and was endorsed by more than 30 organizations.

Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a ...

Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...

The online program "Eating Well with MS" improved dietary behavior among multiple sclerosis patients and was deemed valuable, ...

New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Vitamin D is linked to a 34% reduction in the relative risk for disease activity in patients with clinically isolated ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that ...

Organizations increasingly rely on data-driven insights, and the demand for skilled data professionals continues to rise.